Revolution Medicines, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Revolution Medicines, Inc. (RVMD) reported Increase (Decrease) in Prepaid Expense and Other Assets of $41.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $30.54M, a 314.89% increase year-over-year.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $10.47M.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $3.38M, a 33.94% decline year-over-year.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $5.36M.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $9.67M, a 0.32% decline from fiscal 2024.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $9.70M, a 266.52% increase from fiscal 2023.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $2.65M, a 29.98% decline from fiscal 2022.
- Revolution Medicines, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.78M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $41.01M 10-Q · filed 2026-08-05 | $44.39M derived: sum of 3 quarters · filed 2026-08-05 | $49.74M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $10.47M 10-Q · filed 2026-05-06 | $13.85M derived: sum of 2 quarters · filed 2026-05-06 | $19.20M derived: sum of 3 quarters · filed 2026-05-06 | $26.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.73M derived: sum of 2 quarters · filed 2026-02-25 | $16.09M derived: sum of 3 quarters · filed 2026-08-05 | $9.67M 10-K · filed 2026-02-25 |
| 2025-09-30 | $5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $12.72M derived: sum of 2 quarters · filed 2026-08-05 | $6.29M 10-Q · filed 2025-11-05 | $11.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $935.00K 10-Q · filed 2026-08-05 | $6.05M derived: sum of 3 quarters · filed 2026-08-05 | $1.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$6.43M 10-Q · filed 2026-05-06 | -$1.31M derived: sum of 2 quarters · filed 2026-05-06 | -$5.67M derived: sum of 3 quarters · filed 2026-05-06 | $2.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $755.00K derived: sum of 2 quarters · filed 2026-02-25 | $9.11M derived: sum of 3 quarters · filed 2026-02-25 | $9.70M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.00M derived: sum of 2 quarters · filed 2025-11-05 | $4.59M 10-Q · filed 2025-11-05 | $6.84M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $8.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $8.94M 10-Q · filed 2025-08-06 | $11.20M derived: sum of 3 quarters · filed 2026-02-25 | $12.06M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $590.00K 10-Q · filed 2025-05-07 | $2.84M derived: sum of 2 quarters · filed 2026-02-25 | $3.71M derived: sum of 3 quarters · filed 2026-02-25 | $4.85M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.12M derived: sum of 2 quarters · filed 2026-02-25 | $4.26M derived: sum of 3 quarters · filed 2026-02-25 | $2.65M 10-K · filed 2026-02-25 |
| 2023-09-30 | $870.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.00M derived: sum of 2 quarters · filed 2024-11-06 | $394.00K 10-Q · filed 2024-11-06 | -$4.19M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$476.00K 10-Q · filed 2024-08-07 | -$5.06M derived: sum of 3 quarters · filed 2025-02-26 | -$5.90M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$1.61M 10-Q · filed 2024-05-08 | -$6.20M derived: sum of 2 quarters · filed 2025-02-26 | -$7.03M derived: sum of 3 quarters · filed 2025-02-26 | -$1.25M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$5.42M derived: sum of 2 quarters · filed 2025-02-26 | $363.00K derived: sum of 3 quarters · filed 2025-02-26 | $3.78M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$834.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $4.95M derived: sum of 2 quarters · filed 2023-11-06 | $8.37M 10-Q · filed 2023-11-06 | $7.73M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $9.20M 10-Q · filed 2023-08-08 | $8.56M derived: sum of 3 quarters · filed 2024-02-26 | $7.87M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $3.42M 10-Q · filed 2023-05-08 | $2.78M derived: sum of 2 quarters · filed 2024-02-26 | $2.08M derived: sum of 3 quarters · filed 2024-02-26 | $1.96M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$1.33M derived: sum of 2 quarters · filed 2024-02-26 | -$1.46M derived: sum of 3 quarters · filed 2024-02-26 | -$198.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | -$694.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$817.00K derived: sum of 2 quarters · filed 2022-11-07 | $440.00K 10-Q · filed 2022-11-07 | $282.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.13M 10-Q · filed 2022-08-09 | $976.00K derived: sum of 3 quarters · filed 2023-02-27 | $517.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-09 | $1.10M derived: sum of 2 quarters · filed 2023-02-27 | $640.00K derived: sum of 3 quarters · filed 2023-02-27 | -$21.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$617.00K derived: sum of 2 quarters · filed 2023-02-27 | -$1.28M derived: sum of 3 quarters · filed 2023-02-27 | $1.92M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.12M derived: sum of 2 quarters · filed 2021-11-10 | $2.08M 10-Q · filed 2021-11-10 | $689.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.54M 10-Q · filed 2021-08-11 | $1.15M derived: sum of 3 quarters · filed 2022-02-28 | $3.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $3.20M 10-Q · filed 2021-05-10 | $1.81M derived: sum of 2 quarters · filed 2022-02-28 | $3.77M derived: sum of 3 quarters · filed 2022-02-28 | $3.71M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $563.00K derived: sum of 2 quarters · filed 2022-02-28 | $512.00K derived: sum of 3 quarters · filed 2022-02-28 | $541.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.91M derived: sum of 2 quarters · filed 2020-11-12 | $1.93M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$22.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $29.00K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $909.00K 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |